Originally Published in LSIPR | January 25, 2017
Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017.
This is the finding of a survey outlined in “Life Sciences IP Report”, compiled by Consero Group in partnership with law firm Sterne Kessler Goldstein & Fox.
Almost 50% of IP counsel named global IP strategy as their top area of focus, with another 27% naming research and development.
Paul Mandell, CEO and founder of Consero Group, which provides events for senior-level executives, said: “The report shows that IP leaders in the life sciences industry are focused on setting global strategy while continuing to invest in research and development to grow their company’s IP portfolio.”
See the full article here.